The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: LUPRON     Injury: Prostatic specific antigen increased     Quarter: 2016Q3

Total Records: 9     Number of Pages: 1

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
106338383 LUPRON Prostatic specific antigen increased ASTELLAS 0.00 M 0 20160915 US
111819743 LUPRON Prostatic specific antigen increased ASTELLAS 64.91 YR M 0 20160915 US
111822813 LUPRON Prostatic specific antigen increased ASTELLAS 81.78 YR M 0 20160915 US
111825193 LUPRON Prostatic specific antigen increased ASTELLAS 0.00 M 0 20160915 US
115033952 LUPRON Prostatic specific antigen increased ASTELLAS 69.98 YR M 0 20160915 US
125739042 LUPRON Prostatic specific antigen increased AMGEN 69.00 YR M 0 20160808 US
127495101 LUPRON Prostatic specific antigen increased ASTELLAS 82.05 YR M 0 20160915 US
127506831 LUPRON Prostatic specific antigen increased ASTELLAS 79.53 YR M 0 20160915 US
127507001 LUPRON Prostatic specific antigen increased ASTELLAS 77.70 YR M 0 20160915 US

Total Records: 9     Number of Pages: 1